Literature DB >> 26888905

Evaluation of the Check-Points Check MDR CT103 and CT103 XL Microarray Kits by Use of Preparatory Rapid Cell Lysis.

Scott A Cunningham1, Shawn Vasoo2, Robin Patel3.   

Abstract

Using a rapid bacterial lysis method, the Check MDR CT103 and CT103 XL microarrays demonstrated accuracies of 98.1% and 94.2%, respectively, for detection of known resistance genes in 108 multidrug-resistant Gram-negative bacilli. In 45 isolates, 49 previously unrecognized extended-spectrum β-lactamase or plasmid AmpC targets were detected and confirmed by conventional PCR.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Year:  2016        PMID： 26888905      PMCID： PMC4844729          DOI： 10.1128/JCM.03302-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  28 in total

Review 1.  Current trends in culture-based and molecular detection of extended-spectrum-β-lactamase-harboring and carbapenem-resistant Enterobacteriaceae.

Authors:  Muriel Gazin; Fabienne Paasch; Herman Goossens; Surbhi Malhotra-Kumar
Journal:  J Clin Microbiol       Date:  2012-01-18       Impact factor: 5.948

2.  Using nucleic acid microarrays to perform molecular epidemiology and detect novel β-lactamases: a snapshot of extended-spectrum β-lactamases throughout the world.

Authors:  Christine Lascols; Meredith Hackel; Andrea M Hujer; Steven H Marshall; Sam K Bouchillon; Daryl J Hoban; Stephen P Hawser; Robert E Badal; Robert A Bonomo
Journal:  J Clin Microbiol       Date:  2012-02-08       Impact factor: 5.948

3.  In Vitro Activities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli.

Authors:  Shawn Vasoo; Scott A Cunningham; Nicolynn C Cole; Peggy C Kohner; Sanjay R Menon; Kevin M Krause; Kelly A Harris; Partha P De; Tse Hsien Koh; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

4.  Multicenter evaluation of a new DNA microarray for rapid detection of clinically relevant bla genes from beta-lactam-resistant gram-negative bacteria.

Authors:  Pierre Bogaerts; Andrea M Hujer; Thierry Naas; Roberta Rezende de Castro; Andrea Endimiani; Patrice Nordmann; Youri Glupczynski; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

5.  Evaluation of a commercial microarray to detect carbapenemase-producing Enterobacteriaceae.

Authors:  Neil Woodford; Marina Warner; Rachel Pike; Jiancheng Zhang
Journal:  J Antimicrob Chemother       Date:  2011-09-12       Impact factor: 5.790

6.  Multiplex PCR for detection of acquired carbapenemase genes.

Authors:  Laurent Poirel; Timothy R Walsh; Vincent Cuvillier; Patrice Nordmann
Journal:  Diagn Microbiol Infect Dis       Date:  2011-03-12       Impact factor: 2.803

7.  Evaluation of a DNA microarray for the rapid detection of extended-spectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM).

Authors:  Gaelle Cuzon; Thierry Naas; Pierre Bogaerts; Youri Glupczynski; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2012-05-17       Impact factor: 5.790

Review 8.  Carbapenem resistance in Enterobacteriaceae: here is the storm!

Authors:  Patrice Nordmann; Laurent Dortet; Laurent Poirel
Journal:  Trends Mol Med       Date:  2012-04-03       Impact factor: 11.951

9.  Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.

Authors:  James R Johnson; Carl Urban; Scott J Weissman; James H Jorgensen; James S Lewis; Glen Hansen; Paul H Edelstein; Ari Robicsek; Timothy Cleary; Javier Adachi; David Paterson; John Quinn; Nancy D Hanson; Brian D Johnston; Connie Clabots; Michael A Kuskowski
Journal:  Antimicrob Agents Chemother       Date:  2012-02-21       Impact factor: 5.191

10.  Complete sequencing of pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant Escherichia coli strain isolated in Hong Kong.

Authors:  Pak Leung Ho; Wai U Lo; Man Kiu Yeung; Chi Ho Lin; Kin Hung Chow; Irene Ang; Amy Hin Yan Tong; Jessie Yun-Juan Bao; Si Lok; Janice Yee Chi Lo
Journal:  PLoS One       Date:  2011-03-21       Impact factor: 3.240
View more
  14 in total

1.  Evaluation of a New Commercial Microarray Platform for the Simultaneous Detection of β-Lactamase and mcr-1 and mcr-2 Genes in Enterobacteriaceae.

Authors:  Odette J Bernasconi; Luigi Principe; Regula Tinguely; Aneta Karczmarek; Vincent Perreten; Francesco Luzzaro; Andrea Endimiani
Journal:  J Clin Microbiol       Date:  2017-08-02       Impact factor: 5.948

Review 2.  The Global Ascendency of OXA-48-Type Carbapenemases.

Authors:  Johann D D Pitout; Gisele Peirano; Marleen M Kock; Kathy-Anne Strydom; Yasufumi Matsumura
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

3.  Comparative Evaluation of Assays for Broad Detection of Molecular Resistance Mechanisms in Enterobacterales Isolates.

Authors:  J N Brazelton de Cardenas; C D Garner; Y Su; L Tang; R T Hayden
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

4.  In Vitro Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam against Resistant Gram-Negative Bacilli.

Authors:  Suzannah M Schmidt-Malan; Avisya J Mishra; Ammara Mushtaq; Cassandra L Brinkman; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

5.  Analysis of β-Lactamase Resistance Determinants in Enterobacteriaceae from Chicago Children: a Multicenter Survey.

Authors:  Latania K Logan; Andrea M Hujer; Steven H Marshall; T Nicholas Domitrovic; Susan D Rudin; Xiaotian Zheng; Nadia K Qureshi; Mary K Hayden; Felicia A Scaggs; Anand Karadkhele; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

6.  In Vitro Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli.

Authors:  Wim A Fleischmann; Kerryl E Greenwood-Quaintance; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

7.  A Multi-Centered Case-Case-Control Study of Factors Associated With Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Infections in Children and Young Adults.

Authors:  Latania K Logan; David C Nguyen; Felicia A Scaggs Huang; Nadia K Qureshi; Angella Charnot-Katsikas; Allison H Bartlett; Xiaotian Zheng; Andrea M Hujer; T Nicholas Domitrovic; Steven H Marshall; Robert A Bonomo; Robert A Weinstein
Journal:  Pediatr Infect Dis J       Date:  2019-05       Impact factor: 2.129

8.  Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria.

Authors:  Patrice Nordmann; Laurent Poirel
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 9.079

9.  Evaluation of the BD Phoenix CPO detect panel for prediction of Ambler class carbapenemases.

Authors:  Daniel Jonas; Sandra Reuter; Sarah Klassen; Sabine Weber; Marion Buck; Tommaso Giani; Gian Maria Rossolini; Hajo Grundmann
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.379

10.  Decline in AmpC β-lactamase-producing Escherichia coli in a Dutch teaching hospital (2013-2016).

Authors:  Evert den Drijver; Jaco J Verweij; Carlo Verhulst; Stijn Oome; Joke Soer; Ina Willemsen; Eefje J A Schrauwen; Marjolein F Q Kluytmans-van den Bergh; Jan A J W Kluytmans
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.